Despite the discovery of heterotrimeric αβγ G proteins ~25 years ago, their selective perturbation by cell-permeable inhibitors remains a fundamental challenge.
Investigators report that the plant-derived depsipeptide FR900359 (FR) is ideally suited to this task. Using a multifaceted approach they systematically characterize FR as a selective inhibitor of Gq/11/14 over all other mammalian Gα isoforms and elaborate its molecular mechanism of action.
Authors also use FR to investigate whether inhibition of Gq proteins is an effective post-receptor strategy to target oncogenic signalling, using melanoma as a model system.
FR suppresses many of the hallmark features that are central to the malignancy of melanoma cells, thereby providing new opportunities for therapeutic intervention.
Just as pertussis toxin is used extensively to probe and inhibit the signalling of Gi/o proteins, authors anticipate that FR will at least be its equivalent for investigating the biological relevance of Gq.